Related Experiment Video
Updated: Mar 13, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Systemic Therapy of Advanced/Metastatic Breast Cancer - Current Evidence and Future Concepts
Cornelia Liedtke1, Hans-Christian Kolberg2
1Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein/Campus Lübeck, Lübeck, Germany.
Abstract:
Systemic therapy of metastatic breast cancer may include chemotherapy, endocrine therapy, and targeted therapies (e.g., antibody-based approaches). These agents may be employed alone or in combination based on the patient's breast cancer subtype. Therefore, characterization of the disease phenotype is necessary and may include biopsy of the metastatic site. Novel therapeutic approaches include immunologic therapies, PARP inhibitors, PI3K inhibitors, and CDK4/6 inhibitors, which are currently under investigation in clinical trials.
Insights
Systemic therapy for metastatic breast cancer involves chemotherapy, endocrine, and targeted treatments. Characterizing the cancer subtype is crucial for selecting the most effective treatment approach.
Area of Science:
- Oncology
- Pharmacology
Background:
- Metastatic breast cancer treatment requires tailored systemic therapies.
- Therapeutic options include chemotherapy, endocrine therapy, and targeted agents.
Approach:
- Disease phenotype characterization via biopsy is essential for treatment selection.
- Combination therapies are utilized based on specific breast cancer subtypes.
Key Points:
- Novel treatments under investigation include immunologic therapies, PARP inhibitors, PI3K inhibitors, and CDK4/6 inhibitors.
- These emerging therapies are currently being evaluated in clinical trials.
Conclusions:
- Personalized treatment strategies are key for managing metastatic breast cancer.
- Ongoing research aims to expand therapeutic options for advanced disease.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

